Literature DB >> 11073776

Excess shock and mortality in Staphylococcus aureus related to methicillin resistance.

E N Perencevich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11073776     DOI： 10.1086/317433

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

1.  Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia.

Authors:  Regina B Osih; Jessina C McGregor; Shayna E Rich; Anita C Moore; Jon P Furuno; Eli N Perencevich; Anthony D Harris
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

Review 2.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

3.  Controlling for severity of illness in outcome studies involving infectious diseases: impact of measurement at different time points.

Authors:  Kerri A Thom; Michelle D Shardell; Regina B Osih; Marin L Schweizer; Jon P Furuno; Eli N Perencevich; Jessina C McGregor; Anthony D Harris
Journal:  Infect Control Hosp Epidemiol       Date:  2008-11       Impact factor: 3.254

Review 4.  Antimicrobial resistance and patient outcomes: the hazards of adjustment.

Authors:  Mitchell J Schwaber; Yehuda Carmeli
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

5.  Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.

Authors:  Mesut Yilmaz; Nazif Elaldi; İlker İnanç Balkan; Ferhat Arslan; Ayşe Alga Batırel; Mustafa Zahir Bakıcı; Mustafa Gokhan Gozel; Sevil Alkan; Aygül Doğan Çelik; Meltem Arzu Yetkin; Hürrem Bodur; Melda Sınırtaş; Halis Akalın; Fatma Aybala Altay; İrfan Şencan; Emel Azak; Sibel Gündeş; Bahadır Ceylan; Recep Öztürk; Hakan Leblebicioglu; Haluk Vahaboglu; Ali Mert
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-02-09       Impact factor: 3.944

6.  Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals.

Authors:  Sameer S Kadri; Yi Ling Lai; Sarah Warner; Jeffrey R Strich; Ahmed Babiker; Emily E Ricotta; Cumhur Y Demirkale; John P Dekker; Tara N Palmore; Chanu Rhee; Michael Klompas; David C Hooper; John H Powers; Arjun Srinivasan; Robert L Danner; Jennifer Adjemian
Journal:  Lancet Infect Dis       Date:  2020-09-08       Impact factor: 25.071

7.  Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.

Authors:  Kerri A Thom; Marin L Schweizer; Regina B Osih; Jessina C McGregor; Jon P Furuno; Eli N Perencevich; Anthony D Harris
Journal:  BMC Infect Dis       Date:  2008-09-15       Impact factor: 3.090
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.